Compare EVOK & RCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVOK | RCG |
|---|---|---|
| Founded | 2007 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 18.0M |
| IPO Year | 2013 | N/A |
| Metric | EVOK | RCG |
|---|---|---|
| Price | $11.00 | $2.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 30.4K | 5.9K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,424,652.00 | N/A |
| Revenue This Year | $58.96 | N/A |
| Revenue Next Year | $57.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 67.40 | N/A |
| 52 Week Low | $1.94 | $1.52 |
| 52 Week High | $10.99 | $1.90 |
| Indicator | EVOK | RCG |
|---|---|---|
| Relative Strength Index (RSI) | 85.18 | 53.38 |
| Support Level | $10.66 | $2.54 |
| Resistance Level | $10.99 | $2.65 |
| Average True Range (ATR) | 0.04 | 0.08 |
| MACD | -0.18 | 0.01 |
| Stochastic Oscillator | 95.00 | 89.37 |
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.